TerraBioGen Technologies Inc.

TerraBioGen Technologies Inc.

September 30, 2013 11:00 ET

TerraBioGen Files Third Provisional Patent Application

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 30, 2013) -

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

TerraBioGen Technologies Inc., a developer of proprietary technologies for the production of organic-based, high-value agriculturally bioactive products, announces that it has filed a third provisional patent.

In December 2012, the Company filed provisional patent applications on two microbially-derived agriculturally bioactive materials. The applications include claims related broadly to improving plant health and growth, abiotic and biotic stress tolerance, and improving crop yields.

In September 2013, the Company filed a provisional patent application on its third microbially-derived agriculturally bioactive material and its use in a broad range of applications, including enhanced germination, improved plant health, improved stress tolerance and improved crop yields.

Preliminary results from this year's growing trials have been positive and the Company will be receiving results up to the end of the year. The Company's growing trials have focused on the formulation and delivery of agriculturally bioactive compounds to a wide range of horticultural and agricultural applications.

About TerraBioGen

TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficacy of its technology, its methodology and the quality of its agricultural products. It is further committed to developing a world-wide marketing capability to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Contact Information

  • TerraBioGen Technologies Inc.
    Blair Heffelfinger
    President & CEO
    (604) 444-1023 ext 316
    (604) 444-1043 (FAX)
    bheffelfinger@terrabiogen.com

    TerraBioGen Technologies Inc.
    Bob Nowell
    CFO & Corporate Secretary
    (604) 444-1023 ext 306
    (604) 444-1043 (FAX)
    bnowell@terrabiogen.com